255 related articles for article (PubMed ID: 11295181)
1. Gene targeting in the rodent malaria parasite Plasmodium yoelii.
Mota MM; Thathy V; Nussenzweig RS; Nussenzweig V
Mol Biochem Parasitol; 2001 Apr; 113(2):271-8. PubMed ID: 11295181
[TBL] [Abstract][Full Text] [Related]
2. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
3. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
4. Stable transfection of malaria parasite blood stages.
van Dijk MR; Waters AP; Janse CJ
Science; 1995 Jun; 268(5215):1358-62. PubMed ID: 7761856
[TBL] [Abstract][Full Text] [Related]
5. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
[TBL] [Abstract][Full Text] [Related]
6. Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes.
van Dijk MR; Janse CJ; Waters AP
Science; 1996 Feb; 271(5249):662-5. PubMed ID: 8571132
[TBL] [Abstract][Full Text] [Related]
7. Validation of Plasmodium vivax centromere and promoter activities using Plasmodium yoelii.
Thawnashom K; Kaneko M; Xangsayarath P; Chaiyawong N; Yahata K; Asada M; Adams JH; Kaneko O
PLoS One; 2019; 14(12):e0226884. PubMed ID: 31860644
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium yoelii yoelii 17XNL constitutively expressing GFP throughout the life cycle.
Ono T; Tadakuma T; Rodriguez A
Exp Parasitol; 2007 Mar; 115(3):310-3. PubMed ID: 17049517
[TBL] [Abstract][Full Text] [Related]
9. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
Wu Y; Kirkman LA; Wellems TE
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1130-4. PubMed ID: 8577727
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
[TBL] [Abstract][Full Text] [Related]
11. Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker.
Sultan AA; Thathy V; de Koning-Ward TF; Nussenzweig V
Mol Biochem Parasitol; 2001 Mar; 113(1):151-6. PubMed ID: 11254963
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development.
Miller JL; Harupa A; Kappe SH; Mikolajczak SA
Infect Immun; 2012 Apr; 80(4):1399-407. PubMed ID: 22252874
[TBL] [Abstract][Full Text] [Related]
13. Transfection of the primate malaria parasite Plasmodium knowlesi using entirely heterologous constructs.
van der Wel AM; Tomás AM; Kocken CH; Malhotra P; Janse CJ; Waters AP; Thomas AW
J Exp Med; 1997 Apr; 185(8):1499-503. PubMed ID: 9126931
[TBL] [Abstract][Full Text] [Related]
14. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.
Janse CJ; Ramesar J; Waters AP
Nat Protoc; 2006; 1(1):346-56. PubMed ID: 17406255
[TBL] [Abstract][Full Text] [Related]
15. An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model.
Mikolajczak SA; Aly AS; Dumpit RF; Vaughan AM; Kappe SH
Mol Biochem Parasitol; 2008 Apr; 158(2):213-6. PubMed ID: 18242728
[TBL] [Abstract][Full Text] [Related]
16. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
[TBL] [Abstract][Full Text] [Related]
17. Isolation of invasive Plasmodium yoelii merozoites with a long half-life to evaluate invasion dynamics and potential invasion inhibitors.
Mutungi JK; Yahata K; Sakaguchi M; Kaneko O
Mol Biochem Parasitol; 2015 Nov; 204(1):26-33. PubMed ID: 26684675
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Plasmodium yoelii oocyst development by strain- and stage-specific small-subunit rRNA.
Qi Y; Zhu F; Eastman RT; Fu Y; Zilversmit M; Pattaradilokrat S; Hong L; Liu S; McCutchan TF; Pan W; Xu W; Li J; Huang F; Su XZ
mBio; 2015 Mar; 6(2):e00117. PubMed ID: 25759501
[TBL] [Abstract][Full Text] [Related]
19. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoelii.
Williams CT; Azad AF
PLoS One; 2010 Apr; 5(4):e10267. PubMed ID: 20422005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
